BBVA USA Bancshares’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,198
| Closed | -$1.31M | – | 681 |
|
|
2019
Q3 | $1.31M | Sell |
13,198
-73
| -0.6% | -$6.94K | 0.08% | 200 |
|
|
2019
Q2 | $1.23M | Buy |
13,271
+111
| +0.8% | +$10.5K | 0.07% | 220 |
|
|
2019
Q1 | $1.24M | Sell |
13,160
-501
| -4% | -$43.8K | 0.08% | 211 |
|
|
2018
Q4 | $876K | Sell |
13,661
-3,255
| -19% | -$240K | 0.06% | 246 |
|
|
2018
Q3 | $1.51M | Sell |
16,916
-215
| -1% | -$19K | 0.09% | 208 |
|
|
2018
Q2 | $1.36M | Buy |
17,131
+113
| +0.7% | +$9.38K | 0.09% | 210 |
|
|
2018
Q1 | $1.52M | Sell |
17,018
-770
| -4% | -$73.9K | 0.1% | 204 |
|
|
2017
Q4 | $1.86M | Sell |
17,788
-4,112
| -19% | -$464K | 0.12% | 175 |
|
|
2017
Q3 | $3.19M | Sell |
21,900
-979
| -4% | -$133K | 0.21% | 116 |
|
|
2017
Q2 | $2.97M | Sell |
22,879
-1,600
| -7% | -$196K | 0.2% | 118 |
|
|
2017
Q1 | $3.04M | Buy |
24,479
+185
| +0.8% | +$22.1K | 0.2% | 112 |
|
|
2016
Q4 | $2.81M | Sell |
24,294
-184
| -0.8% | -$20.5K | 0.2% | 121 |
|
|
2016
Q3 | $2.56M | Sell |
24,478
-1,104
| -4% | -$119K | 0.19% | 121 |
|
|
2016
Q2 | $2.52M | Sell |
25,582
-749
| -3% | -$77.5K | 0.19% | 123 |
|
|
2016
Q1 | $2.64M | Buy |
26,331
+2,776
| +12% | +$286K | 0.2% | 112 |
|
|
2015
Q4 | $2.82M | Buy |
23,555
+4,557
| +24% | +$527K | 0.21% | 113 |
|
|
2015
Q3 | $2.06M | Sell |
18,998
-1,299
| -6% | -$161K | 0.16% | 131 |
|
|
2015
Q2 | $2.35M | Sell |
20,297
-1,783
| -8% | -$204K | 0.13% | 147 |
|
|
2015
Q1 | $2.54M | Sell |
22,080
-6,624
| -23% | -$792K | 0.11% | 176 |
|
|
2014
Q4 | $3.21M | Sell |
28,704
-4,049
| -12% | -$427K | 0.15% | 162 |
|
|
2014
Q3 | $3.1M | Sell |
32,753
-20,033
| -38% | -$1.81M | 0.14% | 166 |
|
|
2014
Q2 | $4.53M | Sell |
52,786
-13,652
| -21% | -$1.04M | 0.2% | 139 |
|
|
2014
Q1 | $4.64M | Sell |
66,438
-486
| -0.7% | -$38.5K | 0.21% | 136 |
|
|
2013
Q4 | $5.65M | Sell |
66,924
-720
| -1% | -$57K | 0.25% | 130 |
|
|
2013
Q3 | $5.21M | Sell |
67,644
-3,188
| -5% | -$223K | 0.25% | 129 |
|
|
2013
Q2 | $4.14M | Buy |
+70,832
| New | +$4.26M | 0.21% | 139 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
BBVA USA Bancshares's CELG Position: Q4 2019 in Review
BBVA USA Bancshares sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,198 shares — an estimated $1.31M sold.
BBVA USA Bancshares first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.65M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- BBVA USA Bancshares reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- BBVA USA Bancshares sold 13,198 Celgene Corp shares in Q4 2019, an estimated $1.31M.
- BBVA USA Bancshares first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- BBVA USA Bancshares's Celgene Corp position peaked at $5.65M in Q4 2013.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on BBVA USA Bancshares's 13F filing for Q4 2019, filed 3 Feb 2020.